Прегледање према Аутор Abenavoli L.
Приказивање резултата 9 do 28 od 33
< претходна
следећа >
Датум издавања | Наслов | Аутор(и) |
---|---|---|
2-сеп-2017 | Gut microbiota changes and chronic hepatitis C virus infection | Preveden, Andrej; Scarpellini E.; Milić, Nataša ; Luzza F.; Abenavoli L. |
1-јан-2012 | Haemophagocytic syndrome associated with mucormycosis infection | Arena V.; De-Giorgio F.; Pennacchia I.; Manna R.; Vetrugno G.; Stigliano E.; Milić, Nataša ; Gasbarrini G.; Abenavoli L. |
1-дец-2018 | Hepatitis C virus-induced hepatocellular carcinoma: A narrative review | Ružić, Maja ; Pellicano R.; Fabri M.; Luzza F.; Boccuto L.; Brkić, Miodrag; Abenavoli L. |
1-мар-2017 | The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders | Medić Stojanoska, Milica ; Milošević, Nataša; Milić, Neda; Abenavoli L. |
1-јан-2014 | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 | Abenavoli L.; Masarone M.; Peta V.; Milić, Nataša ; Kobyliak N.; Rouabhia S.; Persico M. |
1-окт-2018 | Iron deficiency anemia and hearing loss | Lemajić Komazec, Slobodanka ; Abenavoli L. |
1-јан-2015 | Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: A case series | Abenavoli L.; Peta V.; Milić, Nataša |
1-мар-2013 | Liver steatosis in celiac disease: The open door | Abenavoli L.; Luigiano C.; Larussa T.; Milić, Nataša ; De Lorenzo A.; Stelitano L.; Morace C.; Consolo P.; Miraglia S.; Fagoonee S.; Virgilio C.; Luzza F.; Pellicano R. |
1-јан-2014 | Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease | Abenavoli L.; Milić, Nataša ; Luigiano C. |
21-авг-2016 | Metabolic aspects of adult patients with nonalcoholic fatty liver disease | Abenavoli L.; Milić, Neda; Di Renzo L.; Preveden, Andrej; Medić Stojanoska, Milica ; De Lorenzo A. |
1-јан-2014 | Metformin in the treatment of non-alcoholic fatty liver disease: Safety, efficacy and mechanism | Rouabhia S.; Milić, Nataša ; Abenavoli L. |
1-нов-2018 | Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases | Abenavoli L.; Izzo A.; Milić, Nataša ; Cicala C.; Santini A.; Capasso R. |
1-мар-2011 | Milk thistle for treatment of nonalcoholic fatty liver disease | Abenavoli L.; Aviello G.; Capasso R.; Milić, Nataša ; Capasso F. |
1-окт-2010 | Milk thistle in liver diseases: Past, present, future | Abenavoli L.; Capasso R.; Milić, Nataša ; Capasso F. |
1-јан-2015 | Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: A close relationship | Abenavoli L.; Di Renzo L.; Guzzi P.; Pellicano R.; Milić, Nataša ; De Lorenzo A. |
1-јан-2019 | Olive oil antioxidants and non-alcoholic fatty liver disease | Abenavoli L.; Milanović, Maja ; Milić, Nataša ; Luzza F.; Giuffrè A. |
1-феб-2013 | A pathogenetic link between non-alcoholic fatty liver disease and celiac disease | Abenavoli L.; Milić, Nataša ; De Lorenzo A.; Luzza F. |
1-јан-2014 | Pharmacotherapy of acute alcoholic hepatitis in clinical practice | Abenavoli L.; Milić, Nataša ; Rouabhia S.; Addolorato G. |
1-јан-2014 | Phytotherapy and nafld-rom goals and challenges to clinical practice | Milošević, Nataša; Milanović, Maja; Abenavoli L.; Milić, Nataša |
1-мар-2019 | Polycystic ovary syndrome and Vitamin D serum levels | Ćetković, Nenad ; Pellicano R.; Bjelica, Artur ; Abenavoli L. |